PFKFB4 negatively regulated the expression of histone acetyltransferase GCN5 to mediate the tumorigenesis of thyroid cancer
Authors:
- 7 January 2020
- journal article
- research article
- Published by Wiley in Development, Growth & Differentiation
- Vol. 62 (2) , 129-138
Abstract
Thyroid cancer (TC) is the most common malignant endocrine tumor, and its incidence has progressively increased over several decades. Accumulating evidence has suggested that PFKFB4, a critical regulatory enzyme of glycolysis, has been implicated in various solid cancers. However, the exact effect of PFKFB4 on TC remains unclear. Hence, the objective of this work was to investigate the role of PFKFB4 in TC and explore the underlying regulatory mechanisms. Here, we provide evidence that mRNA levels of PFKFB4 were upregulated in TC patients’ thyroids and cell lines. Downregulation of PFKFB4 reduced TC cell viability and inhibited colony formation. In addition, the migration and invasion of TC cells were suppressed by PFKFB4 knockdown, suggesting that PFKFB4 is positively correlated with tumorigenesis of TC. Molecularly, knockdown of PFKFB4 significantly inhibited expression of GCN5 and phosphorylation of PI3K/AKT. Moreover, the suppressive role of shPFKFB4 in TC cell growth was reversed by upregulation of GCN5. Finally, the in vivo experiment indicated that downregulation of PFKF4B suppressed tumor growth in xenografts TC model mice. In total, our results suggested that PFKFB4‐mediated TC tumorigenesis by positively regulating GCN5 and PI3K/AKT signaling. These findings provide new research directions and therapeutic options considering PFKF4B as a novel diagnosis marker and therapeutic target.Keywords
This publication has 40 references indexed in Scilit:
- Overexpression of AKT decreases the chemosensitivity of gastric cancer cells to cisplatin in vitro and in vivoMolecular Medicine Reports, 2013
- Akt signalling in health and diseaseCellular Signalling, 2011
- GCN5 regulates the activation of PI3K/Akt survival pathway in B cells exposed to oxidative stress via controlling gene expressions of Syk and BtkBiochemical and Biophysical Research Communications, 2011
- Hypoxia-Inducible Factor in Thyroid CarcinomaJournal of Thyroid Research, 2011
- Expression of hypoxia-inducible factor 1α in thyroid carcinomasEndocrine-Related Cancer, 2010
- Hypoxia, HIF1 and glucose metabolism in the solid tumourNature Reviews Cancer, 2008
- Mitochondrial Autophagy Is an HIF-1-dependent Adaptive Metabolic Response to HypoxiaJournal of Biological Chemistry, 2008
- HER2/PI-3K/Akt activation leads to a multidrug resistance in human breast adenocarcinoma cellsOncogene, 2003
- Variation in survival of adult patients with thyroid cancer in EuropeEuropean Journal of Cancer, 1998
- On the Origin of Cancer CellsScience, 1956